RxDoctor Payments Data

Tatiana Batista

Family Medicine · Chicago, ILNPI 1972612760

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,150 of the $26,419 with a category attached, or 68.7%. Revance Therapeutics, Inc. accounts for 76.0% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $21,942, more than ten times the $460 reported in 2019. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,419in general payments, 2019–2025

Across 187 payments — averaging $141.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Revance Therapeutics, Inc.$20K
  • Merz North America, Inc.$4K
  • AbbVie$932
  • Galderma Laboratories, L.p.$856
  • Takeda Pharmaceuticals U.S.A., Inc.$134
  • Novo Nordisk$115
  • plus $452 from 13 others

What the payments were for

  • Speaking & faculty fees$18,15069%
  • Travel & lodging$1,8767%
  • Food & beverage$6,39324%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,419 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois →

Other family medicine in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →